Shanghai Sanyou Medical Co (688085) Fair Value & Analysis
Healthcare · CN · Market cap 4.5B CNY
Analysis
Shanghai Sanyou Medical Co (688085) currently trades at ¥12.16, while our model-based Fair Value estimate is ¥3.80 — implying the stock looks roughly 68.8% overvalued today. We read business quality at 94/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
About the company
Shanghai Sanyou Medical Co., Ltd. researches, develops, manufactures, and sells orthopedics implants in China. The company offers spinal and trauma implants under Tytus and Sanyou brand. Its spinal products comprise anterior cervical plate, anterior thoracolumbar, posterior cervical, posterior thoracolumbar, and minimally invasive products; and trauma implants, including shoulder and elbow system, hip and pelvis system, knee joint system, foot and ankle, and palm and wrist systems. It also offers sports medicine. Shanghai Sanyou Medical Co., Ltd. was founded in 2005 and is based in Shanghai, China.
Open the full interactive analysis →
Similar stocks
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.